Squadron Capital LLC sells $525k Orthopediatrics (kids) shares
At a glance
- $KIDS today−0.29%last $31.41
- Vs industry peers−0.77 pts6-peer median +0.49% · behind
- Since Sep 4+41.4%from the first trade after the story
- 52-week range9.0% below high$14.42 – $34.53
- Last reported loss$5.9Mquarter to Sep 30, 2026 · 10-Q
- In the headline$525KAmount
Nothing reported about orthopediatrics across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: Drugmakers live and die by pipelines — what is in late-stage trials matters more than this quarter's sales.
- How the stock is trading: $KIDS -0.29% in the latest session.
- Timing: It came out after the closing bell. The session change shown was settled before the story existed, and the next session is the first that could react.
Where the stock stands
OrthoPediatrics ($KIDS) edged down 0.29% to $31.41 in the latest session. Over the past month it is up 42.6%. It now sits 9.0% under the 52-week high of $34.53 and 118% above the year's low of $14.42. It has been a volatile year: the high was 2.4 times the low, so moves this size are not unusual for it.
What the filings say
In its latest report (10-Q, filed Oct 28, 2026), $KIDS lost $5.9M over the quarter to Sep 30, 2026 on revenue of $72.7M (+3.1% QoQ). Operations brought in $2.1M of cash over the nine months to Sep 30, 2026; after capital spending, free cash flow was negative at $6.6M. It carried $101.1M of debt against $17.1M of cash on Sep 30, 2026 — net debt of $84.0M. Its most recent filings before this story: 10-Q on Aug 5, 2026, 8-K on Aug 4, 2026, 8-K on Aug 4, 2026. Figures are as filed with the SEC; the $KIDS page has the full statements.
How much coverage it is getting
Nothing new on OrthoPediatrics has come through Wook's feeds in the last 30 days, so this is still the most recent story on it.
The bigger picture
In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
What to watch next
The company's own filings are the primary source. Its latest SEC reports, including any filing on a material event, are on the $KIDS page, and they say what management has disclosed without a reporter in between. Where several outlets agree is usually the news; where they differ is the angle. To run the numbers yourself, ask Wook AI above about $KIDS: its distance from the high, its last report, or how coverage has changed.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on September 4, 2026. $KIDS has moved +41.36% ($22.22 to $31.41). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
